SynCardia Systems, Inc. IPO Research Information

SynCardia Systems, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on SynCardia Systems, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
SynCardia Systems, Inc.	TAHT - NASDAQ	$10.00-$12.00	$0.00	$0.00	2.5 million
Underwriter(s): Roth Capital Partners
Co-Manager(s): Maxim Group LLC, Monarch Group
Industry:
Filing(s): Filed 2015-08-17 Terms Added 2015-09-16

About SynCardia Systems, Inc. (adapted from SynCardia Systems, Inc. prospectus):
They are a medical technology company focused on developing, manufacturing and commercializing the SynCardia temporary Total Artificial Heart, or TAH-t, an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "TAHT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.